SVRA and HEB among premarket losers

- iextrading.com Posted 5 years ago
Savara (NASDAQ: SVRA ) -76% as Molgradex flunks late-stage aPAP study. More news on: Savara Inc., Hemispherx Biopharma, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more …